| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kambeyanda Shyam | President and CEO, Director | 909 ROSE AVE, 8TH FLOOR, NORTH BETHESDA | /s/ Curtis E. Jewell, Attorney-in-Fact | 25 Feb 2026 | 0001673243 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESAB | Common stock, par value $0.001 | Options Exercise | $1,989,440 | +59,404 | +59% | $33.49 | 159,268 | 23 Feb 2026 | Direct | |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $3,971,113 | -32,286 | -20% | $123.00 | 126,982 | 23 Feb 2026 | Direct | F1, F2 |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $1,571,812 | -12,705 | -10% | $123.72 | 114,277 | 23 Feb 2026 | Direct | F1, F3 |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $1,351,582 | -10,813 | -9.5% | $125.00 | 103,464 | 23 Feb 2026 | Direct | F1, F4 |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $163,527 | -1,300 | -1.3% | $125.79 | 102,164 | 23 Feb 2026 | Direct | F1, F5 |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $76,718 | -600 | -0.59% | $127.86 | 101,564 | 23 Feb 2026 | Direct | F1, F6 |
| transaction | ESAB | Common stock, par value $0.001 | Sale | $218,878 | -1,700 | -1.7% | $128.75 | 99,864 | 23 Feb 2026 | Direct | F1, F7 |
| transaction | ESAB | Common stock, par value $0.001 | Options Exercise | +4,466 | +4.5% | 104,330 | 23 Feb 2026 | Direct | F8 | ||
| transaction | ESAB | Common stock, par value $0.001 | Tax liability | $256,461 | -2,091 | -2% | $122.65 | 102,239 | 23 Feb 2026 | Direct | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ESAB | Employee Stock Option (right to buy) | Options Exercise | $0 | -59,404 | -100% | $0.000000 | 0 | 23 Feb 2026 | Common stock, par value $0.001 | 59,404 | $33.49 | Direct | |
| transaction | ESAB | Restricted Stock Units | Options Exercise | $0 | -4,466 | -50% | $0.000000 | 4,467 | 23 Feb 2026 | Common stock, par value $0.001 | 4,466 | Direct | F8, F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. |
| F2 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.460 to $123.455, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. |
| F3 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.460 to $124.430, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. |
| F4 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.465 to $125.390, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. |
| F5 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.495 to $125.940, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4. |
| F6 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.375 to $128.200, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. |
| F7 | The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.560 to $128.950, inclusive. The reporting person undertakes to provide to ESAB Corporation, any security holder of ESAB Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (7) to this Form 4. |
| F8 | Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. |
| F9 | Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| F10 | This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. The remaining restricted stock units will vest on February 22, 2027. |